Literature DB >> 2183047

High- and low-density lipoproteins enhance infection of Trypanosoma cruzi in vitro.

R P Prioli1, I Rosenberg, M E Pereira.   

Abstract

Trypanosoma cruzi exhibits a developmentally regulated neuraminidase activity that is inhibited by high-density lipoprotein (HDL). We report here that the infection of culture cells by T. cruzi trypomastigotes is enhanced by HDL in a dose-dependent manner. The enhanced infection is prevented by Vibrio cholerae neuraminidase, an enzyme whose activity is not inhibited by HDL, suggesting that sialic acid is involved in T. cruzi-host interaction. Similar enhancement of infection is also produced by low-density lipoprotein (LDL), which inhibits T. cruzi neuraminidase as well as HDL. Further evidence that the enhancement is due to lipoproteins is provided by the fact that infection of host cells in lipoprotein-deficient medium is less than in normal medium; it can be restored to the higher level by the addition of HDL, LDL or both to the lipoprotein-deficient medium. In view of these results, we propose that HDL and LDL regulate T. cruzi infection in mammalian hosts by inhibiting the parasite neuraminidase activity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2183047     DOI: 10.1016/0166-6851(90)90022-e

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  14 in total

1.  Antagonistic effect of atorvastatin on high fat diet induced survival during acute Chagas disease.

Authors:  Dazhi Zhao; Kezia Lizardo; Min Hui Cui; Kamalakar Ambadipudi; Jose Lora; Linda A Jelicks; Jyothi F Nagajyothi
Journal:  Microbes Infect       Date:  2016-07-12       Impact factor: 2.700

2.  Trypanosoma cruzi infection results in an increase in intracellular cholesterol.

Authors:  Christopher Johndrow; Randin Nelson; Herbert Tanowitz; Louis M Weiss; Fnu Nagajyothi
Journal:  Microbes Infect       Date:  2014-01-28       Impact factor: 2.700

3.  The Trypanosoma cruzi neuraminidase contains sequences similar to bacterial neuraminidases, YWTD repeats of the low density lipoprotein receptor, and type III modules of fibronectin.

Authors:  M E Pereira; J S Mejia; E Ortega-Barria; D Matzilevich; R P Prioli
Journal:  J Exp Med       Date:  1991-07-01       Impact factor: 14.307

4.  Invasion of Trypanosoma cruzi into host cells is impaired by N-propionylmannosamine and other N-acylmannosamines.

Authors:  Thorsten Lieke; Daniel Gröbe; Véronique Blanchard; Detlef Grunow; Rudolf Tauber; Martin Zimmermann-Kordmann; Thomas Jacobs; Werner Reutter
Journal:  Glycoconj J       Date:  2011-01-15       Impact factor: 2.916

Review 5.  Chagas' disease.

Authors:  H B Tanowitz; L V Kirchhoff; D Simon; S A Morris; L M Weiss; M Wittner
Journal:  Clin Microbiol Rev       Date:  1992-10       Impact factor: 26.132

6.  Mammalian cell sialic acid enhances invasion by Trypanosoma cruzi.

Authors:  R P Schenkman; F Vandekerckhove; S Schenkman
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

Review 7.  On the interaction of Trypanosoma cruzi neuraminidase and human lipoproteins.

Authors:  R P Prioli; J S Mejia; M E Pereira
Journal:  Eur J Epidemiol       Date:  1991-07       Impact factor: 8.082

8.  Trypanosoma cruzi utilizes the host low density lipoprotein receptor in invasion.

Authors:  Fnu Nagajyothi; Louis M Weiss; David L Silver; Mahalia S Desruisseaux; Philipp E Scherer; Joachim Herz; Herbert B Tanowitz
Journal:  PLoS Negl Trop Dis       Date:  2011-02-01

9.  Trypanosoma cruzi trans-sialidase and neuraminidase activities can be mediated by the same enzymes.

Authors:  S Schenkman; L Pontes de Carvalho; V Nussenzweig
Journal:  J Exp Med       Date:  1992-02-01       Impact factor: 14.307

10.  Desialylation of lysosomal membrane glycoproteins by Trypanosoma cruzi: a role for the surface neuraminidase in facilitating parasite entry into the host cell cytoplasm.

Authors:  B F Hall; P Webster; A K Ma; K A Joiner; N W Andrews
Journal:  J Exp Med       Date:  1992-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.